Abstract
The total nucleotide sequences of the genomes of two Japanese encephalitis virus (JEV) strains, the attenuated vaccine strain SA14-14-2 and its parental virulent strain SA14, were determined by using the molecular cloning technique. The sequence analysis revealed that both virion RNA molecules were 10,976 nucleotides long with 95 and 585 flanking bases at the 5′ and 3′ untranslated sequences, respectively. A single, long open reading frame spanning 10,296 nucleotides was observed to encode a polyprotein of 3432 amino acid residues. When these sequences were compared with each other, 57 nucleotide substitutions were found to be scattered all over the genome. Of these, 24 resulted in amino acid changes within viral proteins. Structural proteins C and E contain one and eight amino acid changes, respectively. Of the nonstructural proteins, NS1 contains three, NS2a two, NS2b two, NS3 four, NS4a one, NS4b one, and NS5 two amino acid substitutions. The 5′- and 3′-terminal untranslated regions contain one- and two-point mutations, respectively. These data and comparative studies with other JEV strain genomes provide a molecular basis for investigating attenuation mechanisms of JEV.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Westaway E.G., Brinton M.A., Gaidamovich S.Ya., Horzinek M.C., Igarashi A., Kaariairnen L., Lvov D.K., Porterfield J.S., Russel P.K. and Trent D.W., Intervirology24, 183–192, 1985.
Rice C.M., Lenches E.M., Eddy S.R., Shin S.J., Sheets R.L. and Strauss J.H., Science229, 726–733, 1985.
Castle E., Leidner U., Nowak T., Wengler G. and Wengler G., Virology149, 10–26, 1986.
Dalgarno L., Trent D.W., Strauss J.H. and Rice C.M., J Mol Biol187, 309–323, 1986.
Hahn Y.S., Galler R., Hunkapiller T., Dalrymple J.M., Strauss J.H. and Strauss E.G., Virology162, 167–180, 1988.
Sumiyoshi H., Mori C., Fuke I., Morita K., Kuhara S., Kondou J., Kikuchi Y., Nagamatsu H. and Igarashi A., Virology161, 497–510, 1987.
Hashimoto H., Nomoto A., Watanabe K., Mori T., Takezawa T., Aizawa C., Takegami T. and Hiramatsu K., Virus Genes1, 305–317, 1988.
Speight G., Coia G., Parker M.D. and Westaway E.G., J Gen Virol69, 23–34, 1988.
Speight G. and Westaway E.G., Virology171, 299–301, 1989.
Chambers T.J., McCourt D.W. and Rice C.M., Virology169, 100–109, 1989.
Burke D.S., in the Committee on Issues and Priorities for New Vaccine Development (ed.)New Vaccine Development, Establishing Priorities, Vol. II. Diseases of Importance in Developing Countries. National Academy Press, Washington DC, 1986, pp. 223–240.
Huang C.H., in Lauffer M.A., Bang F.B., Maramorosch K. and Smith K.M. (eds.)Advances In Virus Research, Vol. 27, Academic Press, New York, 1982, pp. 71–101.
Ao J., Yu Y.X., Tang Y.S., Cui B.C., Jia D.J. and Li H.M., Chin J Microbiol Immunol3, 245–248, 1983.
Igarashi A., J Gen Virol40, 531–544, 1978.
Yu Y.X., Wu P.F., Ao J., Liu L.H. and Li H.M., Chin J Microbiol Immunol1, 77–83, 1981.
Kawamura N., Kohara M., Abe S., Komatsu T., Tago K., Arita M. and Nomoto A., J Virol63, 1302–1309, 1989.
Gubler U. and Hoffman B.J., Gene25, 263–269, 1983.
Sanger F., Nicklen S. and Coulson A.R., Proc Natl Acad Sci USA74, 5463–5467, 1977.
Kuge S. and Nomoto A., J Virol61, 1478–1487, 1987.
Eckels K.H., Yu Y.X., Dubois D.R., Marchette N.J., Trent D.W. and Johnson A.J., Vaccine6, 513–518, 1988.
Kohara M., Abe S., Komatsu T., Tago K., Arita M. and Nomoto A., J Virol62, 2828–2835, 1988.
Evans D.M.A., Dunn G., Minor P.D., Schild G.C., Cann A.J., Stanway G., Almond J.W., Currey K. and Maizel J.V.Jr., Nature (London)314, 548–550, 1985.
Nomoto A., Iizuka N., Kohara M. and Arita M., Vaccine6, 134–137, 1988.
Iizuka N., Kohara M., Hagino-Yamagishi K., Abe S., Komatsu T., Tago K., Arita M. and Nomoto A., J Virol63, 5354–5363, 1989.
Lustig S., Jackson A.C., Hahn C.S., Griffin D.E., Strauss E.G. and Strauss J.H., J Virol62, 2329–2336, 1988.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aihara, S., Chunming, R., Yong-Xin, Y. et al. Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process. Virus Genes 5, 95–109 (1991). https://doi.org/10.1007/BF00571925
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00571925